A prospective cohort study to evaluate the efficacy of OK-432 in reducing seroma formation after axillary dissection
Latest Information Update: 10 Jul 2017
At a glance
- Drugs Picibanil (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 10 Jul 2017 New trial record